SUBSCRIBERS
Biosensors posts 18% Q1 profit fall, sees more competition ahead
Revenue rises 5% but costs and expenses also go up
Published Wed, Aug 6, 2014 · 10:00 PM
BIOSENSORS International Group yesterday posted an 18 per cent fall in its first-quarter net profit on higher costs and expenses.
The medical device manufacturer also warned of greater competition ahead.
"The management expects challenging market conditions such as increased competition and price erosion to continue in the global DES (drug-eluting stents) market," the …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
VinFast chief plans to invest US$1 billion more from his fortune in EV maker
XPeng CEO says its software, AI upgrades to enter ‘super fast cycle’
Asia: Markets mixed as global rally stalls, eyes on yen
Morgan Stanley Asia private equity unit to reorganise as CEO retires